Which progestogen is more likely to increase the risk of fatal myocardial infarction: A combination of epidemiological and trial evidence
To access this article, please choose from the options below
PII: S0378-5122(05)00263-X
doi:10.1016/j.maturitas.2005.10.004
© 2005 Elsevier Ireland Ltd. All rights reserved.
